Jazz Pharmaceuticals plc - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - February 25, 2020

Attached files

file filename
10-K - 10-K - Jazz Pharmaceuticals plcjazz1231201910k.htm
EX-32.1 - CERTIFICATION OF PEO AND INTERIM PFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plcjazzq42019ex321.htm
EX-31.1 - CERTIFICATION OF PEO AND INTERIM PFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcjazzq42019ex311.htm
EX-21.1 - LIST OF SUBSIDIARIES - Jazz Pharmaceuticals plcjazzq42019ex211.htm
EX-10.34D - CASH BONUS PLAN (IRELAND AND OTHER) - Jazz Pharmaceuticals plcjazzq42019ex1034d.htm
EX-10.34C - CASH BONUS PLAN U.S - Jazz Pharmaceuticals plcjazzq42019ex1034c.htm
EX-10.28B - EQUITY AWARD LETTER - Jazz Pharmaceuticals plcjazzq42019ex1028b.htm
EX-10.28A - EMPLOYMENT CONTRACT - Jazz Pharmaceuticals plcjazzq42019ex1028a.htm
EX-10.27 - EMPLOYMENT CONTRACT - Jazz Pharmaceuticals plcjazzq42019ex1027.htm
EX-10.22 - COMPROMISE AGREEMENT - Jazz Pharmaceuticals plcjazzq42019ex1022.htm
EX-10.10 - CONTRACT MANUFACTURING AGREEMENT - Jazz Pharmaceuticals plcjazzq42019ex1010.htm
EX-4.6 - DESCRIPTION OF SHARE CAPITAL - Jazz Pharmaceuticals plcjazzq42019ex46.htm
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors
Jazz Pharmaceuticals plc
We consent to the incorporation by reference in the registration statements (No. 333‑229889, No. 333-224757, No. 333-216338, No. 333-209767, No. 333-202269, No. 333-194131, No. 333-186886 and No. 333-179075) on Form S-8 of Jazz Pharmaceuticals plc of our reports dated February 25, 2020, with respect to the consolidated balance sheets of Jazz Pharmaceuticals plc as of December 31, 2019 and 2018, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2019, and the related notes and financial statement schedule at Item 15(a)2, and the effectiveness of internal control over financial reporting as of December 31, 2019, which reports appear in the December 31, 2019 annual report on Form 10‑K of Jazz Pharmaceuticals plc.

/s/ KPMG

KPMG
Dublin, Ireland
February 25, 2020


Stock widget

Investing forum

Jazz Pharmaceuticals plc Reports